Cannara Biotech Inc. (TSX:LOVE)

Cannara Biotech Revenue

Cannara Biotech had revenue of 30.11M CAD in the quarter ending November 30, 2025, with 20.11% growth. This brings the company's revenue in the last twelve months to 112.36M, up 28.06% year-over-year. In the fiscal year ending August 31, 2025, Cannara Biotech had annual revenue of 107.32M with 30.64% growth.

• Revenue (ttm): 112.36M
• Revenue Growth: +28.06%
• P/S Ratio: 1.47
• Revenue / Employee: 250.03K
• Employees: 452
• Market Cap: 165.95M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Aug 31, 2025	107.32M	25.17M	30.64%
Aug 31, 2024	82.15M	24.59M	42.71%
Aug 31, 2023	57.56M	21.57M	59.91%
Aug 31, 2022	36.00M	18.73M	108.48%
Aug 31, 2021	17.27M	15.17M	723.42%
Aug 31, 2019	2.10M	-	-

Data Source: Fiscal.ai Last updated: Feb 28, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 26, 2026

Data Sources Report a data error